TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorUniversity of Colorado, Denver
About this trial
A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).
Eligibility criteria
Qualifiers
Patients with Barrett's related neoplasia and dysplasia. Patients with esophageal cancer
Disqualifiers
Patients with squamous cell carcinoma
Trial design
Treatments tested in this trial
- Endoscopic eradication therapies (EET)
- Esophagectomy
- Chemotherapy
- Radiation
Treatment groups
5,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Colorado, Denver
Lead sponsor
Northwestern University
Collaborator
University of California, Los Angeles
Collaborator
H. Lee Moffitt Cancer Center and Research Institute
Collaborator
California Pacific Medical Center
Collaborator
Source ClinicalTrials.gov